These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 11476589)

  • 1. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
    Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ
    Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodegenerative changes associated with beta-amyloid deposition in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes.
    Kurt MA; Davies DC; Kidd M; Duff K; Rolph SC; Jennings KH; Howlett DR
    Exp Neurol; 2001 Sep; 171(1):59-71. PubMed ID: 11520121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse.
    Gordon MN; Holcomb LA; Jantzen PT; DiCarlo G; Wilcock D; Boyett KW; Connor K; Melachrino J; O'Callaghan JP; Morgan D
    Exp Neurol; 2002 Feb; 173(2):183-95. PubMed ID: 11822882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathological characterization of mutant amyloid precursor protein yeast artificial chromosome transgenic mice.
    Kulnane LS; Lamb BT
    Neurobiol Dis; 2001 Dec; 8(6):982-92. PubMed ID: 11741394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes.
    McGowan E; Sanders S; Iwatsubo T; Takeuchi A; Saido T; Zehr C; Yu X; Uljon S; Wang R; Mann D; Dickson D; Duff K
    Neurobiol Dis; 1999 Aug; 6(4):231-44. PubMed ID: 10448051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippocampal A beta 42 levels correlate with spatial memory deficit in APP and PS1 double transgenic mice.
    Puoliväli J; Wang J; Heikkinen T; Heikkilä M; Tapiola T; van Groen T; Tanila H
    Neurobiol Dis; 2002 Apr; 9(3):339-47. PubMed ID: 11950278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid cored plaques in Tg2576 transgenic mice are characterized by giant plaques, slightly activated microglia, and the lack of paired helical filament-typed, dystrophic neurites.
    Sasaki A; Shoji M; Harigaya Y; Kawarabayashi T; Ikeda M; Naito M; Matsubara E; Abe K; Nakazato Y
    Virchows Arch; 2002 Oct; 441(4):358-67. PubMed ID: 12404061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylcholinesterase-positive fiber deafferentation and cell shrinkage in the septohippocampal pathway of aged amyloid precursor protein london mutant transgenic mice.
    Bronfman FC; Moechars D; Van Leuven F
    Neurobiol Dis; 2000 Jun; 7(3):152-68. PubMed ID: 10860782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.
    Lewis J; Dickson DW; Lin WL; Chisholm L; Corral A; Jones G; Yen SH; Sahara N; Skipper L; Yager D; Eckman C; Hardy J; Hutton M; McGowan E
    Science; 2001 Aug; 293(5534):1487-91. PubMed ID: 11520987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive effects of PS1 and APP mutations on secretion of the 42-residue amyloid beta-protein.
    Citron M; Eckman CB; Diehl TS; Corcoran C; Ostaszewski BL; Xia W; Levesque G; St George Hyslop P; Younkin SG; Selkoe DJ
    Neurobiol Dis; 1998 Aug; 5(2):107-16. PubMed ID: 9746908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.
    Games D; Adams D; Alessandrini R; Barbour R; Berthelette P; Blackwell C; Carr T; Clemens J; Donaldson T; Gillespie F
    Nature; 1995 Feb; 373(6514):523-7. PubMed ID: 7845465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model.
    Holtzman DM; Fagan AM; Mackey B; Tenkova T; Sartorius L; Paul SM; Bales K; Ashe KH; Irizarry MC; Hyman BT
    Ann Neurol; 2000 Jun; 47(6):739-47. PubMed ID: 10852539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid plaques, neurofibrillary tangles and neuronal loss in brains of transgenic mice overexpressing a C-terminal fragment of human amyloid precursor protein.
    Kawabata S; Higgins GA; Gordon JW
    Nature; 1991 Dec; 354(6353):476-8. PubMed ID: 1793460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease.
    Lorenzo A; Yuan M; Zhang Z; Paganetti PA; Sturchler-Pierrat C; Staufenbiel M; Mautino J; Vigo FS; Sommer B; Yankner BA
    Nat Neurosci; 2000 May; 3(5):460-4. PubMed ID: 10769385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of cortical EEG in mice carrying mutated human APP transgene.
    Wang J; Ikonen S; Gurevicius K; van Groen T; Tanila H
    Brain Res; 2002 Jul; 943(2):181-90. PubMed ID: 12101040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Traumatic brain injury in young, amyloid-beta peptide overexpressing transgenic mice induces marked ipsilateral hippocampal atrophy and diminished Abeta deposition during aging.
    Nakagawa Y; Nakamura M; McIntosh TK; Rodriguez A; Berlin JA; Smith DH; Saatman KE; Raghupathi R; Clemens J; Saido TC; Schmidt ML; Lee VM; Trojanowski JQ
    J Comp Neurol; 1999 Aug; 411(3):390-8. PubMed ID: 10413774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons.
    Van Dorpe J; Smeijers L; Dewachter I; Nuyens D; Spittaels K; Van Den Haute C; Mercken M; Moechars D; Laenen I; Kuiperi C; Bruynseels K; Tesseur I; Loos R; Vanderstichele H; Checler F; Sciot R; Van Leuven F
    Am J Pathol; 2000 Oct; 157(4):1283-98. PubMed ID: 11021833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.
    Schenk D; Barbour R; Dunn W; Gordon G; Grajeda H; Guido T; Hu K; Huang J; Johnson-Wood K; Khan K; Kholodenko D; Lee M; Liao Z; Lieberburg I; Motter R; Mutter L; Soriano F; Shopp G; Vasquez N; Vandevert C; Walker S; Wogulis M; Yednock T; Games D; Seubert P
    Nature; 1999 Jul; 400(6740):173-7. PubMed ID: 10408445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage-correlated distribution of type 1 and 2 dystrophic neurites in cortical and hippocampal plaques in Alzheimer's disease.
    Thal DR; Härtig W; Schober R
    J Hirnforsch; 1998; 39(2):175-81. PubMed ID: 10022341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional phenotype in transgenic mice expressing mutant human presenilin-1.
    Barrow PA; Empson RM; Gladwell SJ; Anderson CM; Killick R; Yu X; Jefferys JG; Duff K
    Neurobiol Dis; 2000 Apr; 7(2):119-26. PubMed ID: 10783295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.